{
    "clinical_study": {
        "@rank": "52143", 
        "acronym": "HPV-004", 
        "arm_group": [
            {
                "arm_group_label": "A1", 
                "arm_group_type": "Active Comparator", 
                "description": "A1) Cytological screening in A1 and A3. Frequent information of screening results for cytology and/or HPV DNA at the ages of 22 (cytology only), 25 and 30."
            }, 
            {
                "arm_group_label": "A2", 
                "arm_group_type": "No Intervention", 
                "description": "A2) infrequent information of screening results, only at the age 30 years."
            }, 
            {
                "arm_group_label": "A3", 
                "arm_group_type": "Other", 
                "description": "A3) Cytological screening in A1 and A3. With at least 1000 participants is enrolled for interim safety analysis when the 1992 birth cohort is 25 years of age and cytology results are being revealed."
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of the study is to identify whether or not being informed infrequently\n      results about screening is: 1) At least as safe and accurate as frequently obtaining all\n      information from the present combination of opportunistic/organized cervical screening by\n      comparing regimen results of three screening visits at the ages of 22, 25 and 30 years (Arm\n      A1) vs. results of one screening visit at the age of 30 years (Arm A2) in Human\n      papillomavirus (HPV) vaccinated young women."
        }, 
        "brief_title": "Effectiveness of Cervical Screening in HPV Vaccinated Women", 
        "completion_date": {
            "#text": "January 2024", 
            "@type": "Anticipated"
        }, 
        "condition": "Cervical Intraepithelial Neoplasia Grade 2/3", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Cervical Intraepithelial Neoplasia", 
                "Uterine Cervical Dysplasia", 
                "Carcinoma in Situ"
            ]
        }, 
        "detailed_description": {
            "textblock": "Altogether 16.500 1992-1995 born women vaccinated with the bi-valent human papillomavirus\n      type 16 and 18 (HPV16/18) vaccine as adolescents either at the age of 12 to 15 or at the age\n      of 18 will be invited to an effectiveness trial at the age of 22 years, and randomized into\n      Arms A1 and A2, and A3, respectively.\n\n      Cervical samples and cervico-vaginal self-samples rinsed in first-void urine will be\n      analysed for HPV and C. trachomatis DNA with MGP primer system followed by MALDITOF mass\n      spectrometry on the SEQUENOM platform (HPV) and the Abbott\u2122  PCR (Chlamydia  trachomatis),\n      respectively.\n\n      With assumed >50% participation the trial has 80% power to show non-inferiority of the\n      infrequent vs. the frequent screening information.\n\n      A one-way (participant) blinded interim analysis among the 1992-born study participants in\n      A1 and A3 arms, who have attended the 2nd study visit at the age of 25 years, will be\n      performed in 2017 for assuring no statistically significant differences in the cervical\n      intraepithelial neoplasia grade 2/3 (CIN2/CIN3) incidences of the two arms.\n\n      At the study end testing the null hypotheses of no difference in the incidence of the CIN2/3\n      end-points between the A1 and A2 intervention arms will be done using the Mantel-Haenszel\n      one degree of freedom chi-square statistics."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  HPV 16/18 vaccinated. Born 1992-1995.\n\n        Exclusion Criteria:\n\n          -  Immunocompromising disease. HPV 6/11/16/18 vaccination."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "22 Years", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "7500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02149030", 
            "org_study_id": "HPV-004"
        }, 
        "intervention": {
            "arm_group_label": [
                "A1", 
                "A3"
            ], 
            "description": "Cytological screening.", 
            "intervention_name": "Cytological screening in A1 and A3", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Helsinki", 
                        "country": "Finland"
                    }, 
                    "name": "HUS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hyvink\u00e4\u00e4", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "H\u00e4meenlinna", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iisalmi", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Joensuu", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jyv\u00e4skyl\u00e4", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "J\u00e4ms\u00e4", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kajaani", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kemi", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kokkola", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kotka", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kouvola", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kuopio", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lahti", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lappeenranta", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lohja", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mikkeli", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oulu", 
                        "country": "Finland"
                    }, 
                    "name": "THL"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pori", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porvoo", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rauma", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rovaniemi", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salo", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Savonlinna", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sein\u00e4joki", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampere", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Turku", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vaasa", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vammala", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varkaus", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u00c4\u00e4nekoski", 
                        "country": "Finland"
                    }, 
                    "name": "Nuorisotutkimusasema: Tampereen yliopisto"
                }
            }
        ], 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effectiveness of Cervical Screening in HPV Vaccinated Women - A Randomized Trial", 
        "overall_official": {
            "affiliation": "University of Tampere", 
            "last_name": "Matti Lehtinen, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Finland: Finnish Medicines Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2024", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "1a) No marked difference in the incidence of CIN2/3 between arms A1 (participants frequently informed of the cytological results) and A3 (participants not informed of the cytological findings at the age of 22) (interim analysis). 1b) No difference in the incidence of CIN2/3 between arms A1 (participants frequently informed of the cytological results) and A2 (participants infrequently informed of the cytological results).\nThe participants will be followed for 9 years starting from the year they turn 22. For 1992 born the follow-up will start in 2014 and end in 2023. For 1995 born the follow-up will start in 2017 and end in 2026.\nThe interim analysis will include only 1992 cohort. The final analysis will include all cohorts (1992, 1993, 1994, 1995).", 
            "measure": "Occurrence of intraepithelial neoplasia grade 2/3 (CIN2/3).", 
            "safety_issue": "Yes", 
            "time_frame": "2017(interim), 2026 (final analysis). Participants will be followed for the duration of the study until 2026, an expected average of 9 years."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02149030"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Tampere", 
            "investigator_full_name": "Matti Lehtinen", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Tampere", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "European Union", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Academy of Finland", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Cancer Society of Finland", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Tampere", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}